Today: 20 March 2026
Subscribe
Browse Category

TSX:9501 25 November 2025 - 5 January 2026

Tokyo stocks today: Nikkei starts 2026 higher as TEPCO, chip and defense names lead

Tokyo stocks today: Nikkei starts 2026 higher as TEPCO, chip and defense names lead

Japan’s Nikkei 225 surged 3.03% to 51,865 in its first 2026 session, led by a 9.23% jump in TEPCO after it announced plans to restart a reactor this month. Chip and defense stocks rallied, while the yen weakened to 157.295 per dollar. S&P Global’s December manufacturing PMI held at 50.0. Investors now await the BOJ’s Jan. 22-23 meeting and U.S. jobs data due Jan. 9.
5 January 2026
········
Tokyo Stock Market Today: NTT, Sony Financial and TEPCO Dominate Most Active Stocks on Dec. 9, 2025

Tokyo Stock Market Today: NTT, Sony Financial and TEPCO Dominate Most Active Stocks on Dec. 9, 2025

The Nikkei 225 closed up 0.14% at 50,651.75 Tuesday after a 7.5-magnitude earthquake struck off Japan’s northeast coast late Monday, prompting tsunami warnings and evacuations for 90,000 people. Semiconductor shares led gains. Authorities reported about 30 injuries and brief power outages, but no major damage or nuclear plant issues. The yen steadied after initial weakness.
9 December 2025
····
Tokyo Stock Market’s Biggest Gainers Today (December 9, 2025): Chip Makers, Industrials and Utilities Drive the Nikkei 225 Higher

Tokyo Stock Market’s Biggest Gainers Today (December 9, 2025): Chip Makers, Industrials and Utilities Drive the Nikkei 225 Higher

Tokyo’s Nikkei 225 closed near 50,700, up 0.2% after a volatile session led by gains in semiconductor and factory-automation stocks including Disco and Fanuc. Energy and auto-related shares such as TEPCO and Yokohama Rubber also advanced. Investors remained cautious ahead of a possible U.S. Federal Reserve rate cut and a Bank of Japan policy meeting later this month.
9 December 2025
·········
TEPCO Stock Today (TSE:9501): Nuclear Restart Momentum, AI Power Demand and a 3% Climb – November 27, 2025

TEPCO Stock Today (TSE:9501): Nuclear Restart Momentum, AI Power Demand and a 3% Climb – November 27, 2025

TEPCO shares closed at ¥825.1 in Tokyo on November 27, up 3.06% for a third straight gain, as investors reacted to progress on restarting the Kashiwazaki-Kariwa nuclear plant. Trading volume reached about 40.9 million shares. The move comes despite a ¥712 billion half-year net loss linked to Fukushima costs. The stock remains below its mid-November high of ¥939.4.
27 November 2025
··
Tokyo Electric Power Company Holdings Stock Today (Nov. 26, 2025): Price Rebounds as Nuclear Restart Nears and Fresh Grant Arrives

Tokyo Electric Power Company Holdings Stock Today (Nov. 26, 2025): Price Rebounds as Nuclear Restart Nears and Fresh Grant Arrives

TEPCO shares closed up 3.3% at ¥790.8 in Tokyo on Wednesday, rebounding after a 6.4% plunge the previous day. The move follows news of a fresh ¥10.9 billion government-backed grant for Fukushima compensation and renewed momentum toward restarting the Kashiwazaki-Kariwa nuclear plant. Trading volume dropped to 25.2 million shares from Tuesday’s 183 million.
26 November 2025
··
Japan Stock Market Today: Nikkei 225 Ends Flat as SoftBank Crashes on AI Jitters – November 25, 2025

Japan Stock Market Today: Nikkei 225 Ends Flat as SoftBank Crashes on AI Jitters – November 25, 2025

SoftBank Group shares plunged 9.95% in Tokyo on Tuesday, erasing most of the Nikkei 225’s early gains and wiping an estimated 338 points from the index. The Nikkei closed up just 0.07% at 48,659.52 after surging more than 1% at the open, while the Topix slipped 0.21%. Turnover on the Topix was above the three-month average.
25 November 2025
·········

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop